bronchopulmonary dysplasia/headache

The past year has provided us with some interesting studies concerning pharmacology and anesthesia during the puerperium. I review the prevalence of various anesthetic techniques, as well as the use of different aspiration prophylaxis regimens. I also look at innovations in the administration of

BACKGROUND Respiratory distress syndrome (RDS) is caused by a deficiency of pulmonary surfactant (an active agent that keeps pulmonary alveoli open and facilitates the entry of air to the lungs, thus improving the oxygenation of the newborn).A number of interventions such as pulmonary surfactant and

Pre‐eclampsia (PE) is a multisystem disorder that typically affects 2%–5% of pregnant women and is one of the leading causes of maternal and perinatal morbidity and mortality, especially when the condition is of early onset. Globally, 76 000 women and 500 000 babies die each year from this disorder.